Cyclerion Therapeutics, Inc. Human Resources Contracts & Agreements
13 Contracts & Agreements
- Bonus & Incentive Agreements (2 contracts)
- Compensation Agreements (2)
- Consulting Agreements (1)
- Employment Agreements (1)
- Separation Agreements (3)
- Severance Agreements (2)
- Transition Agreements (2)
- Consulting Agreement with Peter Hecht dated December 1, 2023 (Filed With SEC on March 5, 2024)
- Amended and Restated Recognition Bonus Agreement, dated December 21, 2022, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault (Filed With SEC on March 5, 2024)
- Amended and Restated Recognition Bonus Agreement, dated December 21, 2022, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino (Filed With SEC on March 5, 2024)
- Separation and Release of Claims Agreement, dated October 17, 2023, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino (Filed With SEC on October 23, 2023)
- Separation Agreement, effective June 26, 2023, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault (Filed With SEC on July 28, 2023)
- Cyclerion Therapeutics, Inc. Executive Severance Plan (Filed With SEC on August 9, 2022)
- Non-Employee Director Compensation Plan (amended and restated as of December 17, 2021) (Filed With SEC on May 4, 2022)
- Employment Agreement, effective April 29, 2019, by and between Cyclerion GmbH and Andreas Busch (Filed With SEC on May 4, 2022)
- Cyclerion Therapeutics, Inc. Executive Severance Plan (Filed With SEC on September 25, 2019)
- Non-Employee Director Compensation Plan (effective June 1, 2019) (Filed With SEC on August 12, 2019)
- Separation Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc (Filed With SEC on April 2, 2019)
- Transition Services Agreement, dated as of April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc (Filed With SEC on April 2, 2019)
- Transition Services Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc (Filed With SEC on April 2, 2019)
